Boston Scientific's CE-marks embolic filter for expanded use:
This article was originally published in Clinica
Executive Summary
Boston Scientific has CE-marked for sale in Europe its Filterwire EX embolic protection device for use in coronary and saphenous vein graft applications. The device is designed to capture embolic material that become dislodged during vascular interventional procedures and that might otherwise travel through the blood to the heart or brain causing a heart attack or stroke. It was CE-marked for use in the peripheral circulatory system last October. Boston, of Natick, Massachusetts, acquired the product earlier this year after buying US firm Embolic Protection (see Clinica No 947, p 13).
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.